• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY (BD) BD PAXGENE® BLOOD DNA TUBE; BLOOD SPECIMEN COLLECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY (BD) BD PAXGENE® BLOOD DNA TUBE; BLOOD SPECIMEN COLLECTION DEVICE Back to Search Results
Catalog Number 762165
Device Problem Device Ingredient or Reagent Problem (2910)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/13/2022
Event Type  malfunction  
Event Description
It was reported when using the bd paxgene® blood dna tubes, the device experienced discolored / abnormal additive form.The following information was provided by the initial reporter.The customer stated: we met with this lot 1021404 of paxgene blood rna ref 762165 at least 5% failure in analysis of degraded rna could we have a different lot with an expiry > to 30/11/2022 please, thank you.
 
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported when using the bd paxgene® blood dna tubes, the device experienced discolored / abnormal additive form.The following information was provided by the initial reporter.The customer stated: we met with this lot 1021404 of paxgene blood rna ref (b)(4) at least 5% failure in analysis of degraded rna.Could we have a different lot with an expiry > 30/11/2022? please, thank you.
 
Manufacturer Narrative
H.6.Investigation summary: material #: 762165, lot/batch: #1021404.Bd had not received samples or photos for evaluation.Therefore, retention samples of the incident lot were selected from bd inventory for evaluation and upon completion, no issues relating to erroneous results were observed.No difficulties were encountered during blood collection and all tubes appeared to exhibit proper fill.Retain and control tubes performed as expected with regards to fill functionality.The reported issue is generally associated with the rna isolation procedures.If the customer is using the paxgene blood rna kit for purification, it is advised to contact our joint venture partner, (b)(4) customer service for technical assistance.Application support for individual protocols is not available through bd.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint is unable to be confirmed for the indicated failure mode erroneous results.Bd was not able to identify a root cause for the indicated failure mode.Factors that may contribute to erroneous results were evaluated through a clinical study to verify the design of the device met it¿s intended use.The result of the study showed that the device performed as expected and we were unable to determine any external contributor to this reported issue.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PAXGENE® BLOOD DNA TUBE
Type of Device
BLOOD SPECIMEN COLLECTION DEVICE
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY (BD)
belliver way
belliver industrial estate
plymouth
UK 
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY (BD)
belliver way
belliver industrial estate
plymouth
UK  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14476655
MDR Text Key293356801
Report Number9617032-2022-00509
Device Sequence Number1
Product Code NTW
UDI-Device Identifier04053727621658
UDI-Public04053727621658
Combination Product (y/n)N
Reporter Country CodeFP
PMA/PMN Number
K082150
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/23/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date11/30/2022
Device Catalogue Number762165
Device Lot Number1021404
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-